| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |